RxDoctor Payments Data

Muhamed Saric, MD

Cardiovascular Disease · Newark, NJNPI 1952497257

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $103,828 of the $159,345 with a category attached, or 65.2%. 9 manufacturers reported payments, led by Abbott at 42.5% of the total. Reporting peaked in 2019 at $54,767 and has fallen 54.2% since, to $25,085 in 2025. Among cardiovascular disease clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$159,345in general payments, 2019–2025

Across 248 payments — averaging $642.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$68K
  • Medtronic$61K
  • Siemens Medical Solutions USA, Inc.$11K
  • Boston Scientific$10K
  • Livanova USA, Inc.$7K
  • Edwards Lifesciences$2K
  • plus $368 from 3 others

What the payments were for

  • Consulting fees$26,62517%
  • Speaking & faculty fees$103,82865%
  • Travel & lodging$20,91113%
  • Food & beverage$7,9805%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$159,345 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.

See all cardiovascular disease providers in New Jersey

Medicare billing

Part B allowed, 2024
$62,001
Medicare patients
456
Services billed
993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →